Avery Dennison Smartrac launches ultra-small AD Minidose U9 RFID inlay for pharma applications

Avery Dennison Smartrac launches ultra-small AD Minidose U9 RFID inlay for pharma applications

GLENDALE, CA – February 10, 2022 — Avery Dennison Smartrac today launched its AD Minidose U9 RAIN RFID inlay for pharmaceutical applications, unlocking critical RFID value for healthcare, pharmacies, and laboratory asset management. AD Minidose U9 is one of the smallest products on the market to receive ARC certification (Spec S) from Auburn University’s RFID Lab, and to be approved for use by the DoseID industry consortium.

AD Minidose U9 builds on the success of the Minidose U8 inlay launched in 2021, and performs in the standard UHF RFID frequency band between 860MHz-960MHz, with a small form factor of 22x12mm. With its long read range, even in densely packed inventory environments, AD Minidose U9 is certified to work on all current DoseID product categories. The inlay uses NXP’s proven UCODE®️ 9 IC, which is equipped with 96 bits of EPC memory, including a 96-bit Tag IDentifier (TID) with a 48-bit unique serial number factory-encoded into the TID. 

Max Winograd, vice president, connected products at Avery Dennison Smartrac, said, “AD Minidose U9 meets the needs for a wide range of pharmaceutical item-level use cases. The inlay performs robustly on clear and amber glass as well as plastics and syringes, even when filled with pharmaceuticals and biologicals. This unlocks critical RFID value for asset and inventory management in multiple pharma or healthcare applications. It also meets specific customer requirements with the goal of ensuring patient safety, increasing nursing “time to care,” and decreasing inefficiencies in the operational process.”

Avery Dennison Smartrac is a key RFID partner for Kit Check®, a leading provider of automated medication tracking and diversion detection solutions for hospital pharmacies in the U.S. and has supplied RFID tags for the Kit Check application since its inception. The Kit Check RFID-enabled inventory management solution helps hospitals modernize restocking processes and automates them to save redundant drug spend and ensure patient safety.

According to Tim Kress-Spatz, Kit Check co-founder, “Kit Check's inventory of pharmaceutical containers continues to expand by adding different series of containers in various sizes. We pursue to work successfully with Avery Dennison Smartrac, and their product line continuously evolves to meet our needs. We tag a myriad of pharmaceuticals through the Kit Check solution to deliver the right medicine, to the right patient at the right time, every time." 

Available as wet and dry inlays with the NXP UCODE 9 IC, AD Minidose U9 will ship in volume from Q2 2022. AD Minidose U9 inlays are compliant with ISO 9001:2015 Quality Management and ISO 14001:2015 Environmental Management, which ensures a reliable and state-of-the-art product that meets a variety of application needs. They are manufactured according to the industry’s highest quality standards, as confirmed by the RFID Lab at Auburn University, which awarded Avery Dennison Smartrac its first-ever ARC accreditation for overall design and manufacturing quality.

Media contact

Christian Achenbach
Communications Manager, Avery Dennison Smartrac
christian.achenbach@eu.averydennison.com


About Avery Dennison
Avery Dennison (NYSE: AVY) is a global materials science company specializing in the design and manufacture of a wide variety of labeling and functional materials. The company’s products, which are used in nearly every major industry, include pressure-sensitive materials for labels and graphic applications; tapes and other bonding solutions for industrial, medical, and retail applications; tags, labels and embellishments for apparel; and radio frequency identification (RFID) solutions serving retail apparel and other markets. Headquartered in Glendale, California, the company employs more than 35,000 employees in more than 50 countries. Reported sales in 2021 were $8.4 billion. Learn more at www.averydennison.com.

About Kit Check
Kit Check® is the leading provider of automated solutions for hospital pharmacies in the U.S., bringing visibility, simplicity, and predictability to the complex world of medication supply management. Our groundbreaking Medication Intelligence™ solutions provide item-level visibility, workflow simplicity, and actionable analytics, empowering stakeholders to deliver the right medicine to the right patient at the right time, every time. To date, our more than 700 U.S. and Canadian hospital partners have adopted Kit Check solutions to solve the most challenging of healthcare problems. Kit Check Solutions help providers save time managing inventory, prevent diversion at their facilities, save money on medication spend, and ensure patient safety. More information about Kit Check and our software solutions can be found at kitcheck.com.

About DoseID
DoseID is the first member-driven industry consortium for the use of radio-frequency identification (RFID) technology in the healthcare space. DoseID consists of industry innovators who are committed to increasing the interoperability, quality and performance of RFID-tagged products as they move through the pharmaceutical supply chain from manufacturer to patient. 

The DoseID RFID tag certification is provided by Auburn University RFID Lab’s ARC Program. This ensures that parties not only meet the standards set by the consortium, but that the established standards meet the needs of industry players including pharmaceutical manufacturers, 503b compounding pharmacies, pharmacy automation vendors, and inlay and tag manufacturers. Members of DoseID, which launched in August 2020, hail from other companies across the pharmaceutical supply chain including health systems. Learn more about DoseID at doseid.com

© 2022 Avery Dennison Corporation, All Rights Reserved.

Various trademarks and trade names are used herein and are the property of their respective owners.